380 related articles for article (PubMed ID: 30804940)
1. Immune Responses to the Sexual Stages of
Kengne-Ouafo JA; Sutherland CJ; Binka FN; Awandare GA; Urban BC; Dinko B
Front Immunol; 2019; 10():136. PubMed ID: 30804940
[TBL] [Abstract][Full Text] [Related]
2. Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.
de Jong RM; Tebeje SK; Meerstein-Kessel L; Tadesse FG; Jore MM; Stone W; Bousema T
Immunol Rev; 2020 Jan; 293(1):190-215. PubMed ID: 31840844
[TBL] [Abstract][Full Text] [Related]
3. Naturally acquired immunity to sexual stage P. falciparum parasites.
Stone WJ; Dantzler KW; Nilsson SK; Drakeley CJ; Marti M; Bousema T; Rijpma SR
Parasitology; 2016 Feb; 143(2):187-98. PubMed ID: 26743529
[TBL] [Abstract][Full Text] [Related]
4. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
Gebru T; Ajua A; Theisen M; Esen M; Ngoa UA; Issifou S; Adegnika AA; Kremsner PG; Mordmüller B; Held J
Malar J; 2017 Apr; 16(1):176. PubMed ID: 28446190
[TBL] [Abstract][Full Text] [Related]
5. PIMMS43 is required for malaria parasite immune evasion and sporogonic development in the mosquito vector.
Ukegbu CV; Giorgalli M; Tapanelli S; Rona LDP; Jaye A; Wyer C; Angrisano F; Blagborough AM; Christophides GK; Vlachou D
Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7363-7373. PubMed ID: 32165544
[TBL] [Abstract][Full Text] [Related]
6. [Plasmodium vivax and Plasmodium falciparum gametocyte stages are neglected in vaccine development].
Contreras-Ochoa C; Ramsey JM
Salud Publica Mex; 2004; 46(1):64-70. PubMed ID: 15053398
[TBL] [Abstract][Full Text] [Related]
7. Structural vaccinology of malaria transmission-blocking vaccines.
Patel PN; Tolia N
Expert Rev Vaccines; 2021 Feb; 20(2):199-214. PubMed ID: 33430656
[No Abstract] [Full Text] [Related]
8. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
Sutherland CJ
Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
[TBL] [Abstract][Full Text] [Related]
9. Plasmodium falciparum Calcium-Dependent Protein Kinase 4 is Critical for Male Gametogenesis and Transmission to the Mosquito Vector.
Kumar S; Haile MT; Hoopmann MR; Tran LT; Michaels SA; Morrone SR; Ojo KK; Reynolds LM; Kusebauch U; Vaughan AM; Moritz RL; Kappe SHI; Swearingen KE
mBio; 2021 Dec; 12(6):e0257521. PubMed ID: 34724830
[TBL] [Abstract][Full Text] [Related]
10. The march toward malaria vaccines.
Hoffman SL; Vekemans J; Richie TL; Duffy PE
Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
[TBL] [Abstract][Full Text] [Related]
11. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
Høgh B
Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
[TBL] [Abstract][Full Text] [Related]
12. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
Gowda DC; Wu X
Front Immunol; 2018; 9():3006. PubMed ID: 30619355
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
Paul NH; Vengesai A; Mduluza T; Chipeta J; Midzi N; Bansal GP; Kumar N
Acta Trop; 2016 Nov; 163():103-8. PubMed ID: 27491342
[TBL] [Abstract][Full Text] [Related]
14. Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African
Muthui MK; Kamau A; Bousema T; Blagborough AM; Bejon P; Kapulu MC
Front Immunol; 2019; 10():2480. PubMed ID: 31695697
[No Abstract] [Full Text] [Related]
15. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
16. Mosquito Vectors and the Globalization of Plasmodium falciparum Malaria.
Molina-Cruz A; Zilversmit MM; Neafsey DE; Hartl DL; Barillas-Mury C
Annu Rev Genet; 2016 Nov; 50():447-465. PubMed ID: 27732796
[TBL] [Abstract][Full Text] [Related]
17. Transmission-Blocking Vaccines: Old Friends and New Prospects.
Acquah FK; Adjah J; Williamson KC; Amoah LE
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30962400
[TBL] [Abstract][Full Text] [Related]
18. Immune mechanisms targeting malaria transmission: opportunities for vaccine development.
Bansal GP; Kumar N
Expert Rev Vaccines; 2024; 23(1):645-654. PubMed ID: 38888098
[TBL] [Abstract][Full Text] [Related]
19. Strategies & recent development of transmission-blocking vaccines against
Chaturvedi N; Bharti PK; Tiwari A; Singh N
Indian J Med Res; 2016 Jun; 143(6):696-711. PubMed ID: 27748294
[TBL] [Abstract][Full Text] [Related]
20. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
